Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That Are Considered at Higher Risk of Severe COVID-19

← catalyst calendar

NCT07222384

Sponsored by BioNTech SE (industry) · BNTX — their whole pipeline →. With Pfizer.

Phase
Phase 3
Status
Completed
Study type
Interventional
Design
Na · None · Prevention
Enrollment
344actual
Sites
29
Countries
Puerto Rico, United States

Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →

Source: ClinicalTrials.gov, retrieved 2026-08-19

Dates

each axis at the precision it was filed, with the registry's own basis
DateFiledBasisWhat it is
Start2025-10-30actualWhen the study began enrolling
Primary completion2026-07-24actualThe date the last participant is measured for the primary outcome — the readout window
Study completion2026-07-24actualThe whole study's end, after follow-up
First posted2025-10-29actualWhen this record first appeared on the registry
Results postedWhen the sponsor posted results to the registry
Record updated2026-08-07actualThe sponsor's own last edit to this record — every projection above is as current as this date

What it studies

Conditions

  • COVID-19
  • SARS-COV-2 Infection

Intervention

  • Biological: BNT162b2 (2025/2026 formulation)

Primary outcomes

what the primary-completion date above is the date OF
Percentage of participants reporting local reactions
measured For up to 7 days after vaccination
Percentage of participants reporting systemic events
measured For up to 7 days after vaccination
Percentage of participants reporting adverse events
measured Through 1 month after vaccination
Percentage of participants reporting serious adverse events
measured Through 6 months after vaccination
Geometric Mean Fold Rises (GMFRs)
measured From before vaccination to 1 month after vaccination

Permalink · BNTX's whole pipeline · Catalyst calendar · Every registered study · What changed